Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - Deferred ChargesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

Molecular Partners Ag (MOLN) EPS (Basic): 2022-2024

Historic EPS (Basic) for Molecular Partners Ag (MOLN) over the last 3 years, with Dec 2024 value amounting to -$1.81.

  • Molecular Partners Ag's EPS (Basic) rose 30.65% to -$0.00 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.86, marking a year-over-year increase of 12.67%. This contributed to the annual value of -$1.81 for FY2024, which is 14.12% up from last year.
  • Per Molecular Partners Ag's latest filing, its EPS (Basic) stood at -$1.81 for FY2024, which was up 14.12% from -$2.10 recorded in FY2023.
  • Over the past 5 years, Molecular Partners Ag's EPS (Basic) peaked at $3.77 during FY2022, and registered a low of -$2.10 during FY2023.
  • Moreover, its 3-year median value for EPS (Basic) was -$1.81 (2024), whereas its average is -$0.05.
  • In the last 5 years, Molecular Partners Ag's EPS (Basic) crashed by 155.85% in 2023 and then climbed by 14.12% in 2024.
  • Molecular Partners Ag's EPS (Basic) (Yearly) stood at $3.77 in 2022, then plummeted by 155.85% to -$2.10 in 2023, then climbed by 14.12% to -$1.81 in 2024.